preventing bone loss and ensuring normal bone regeneration [11] . Osteoblast specific transcription factor Runt-related transcription factor 2 (RUNX-2) and fat formation key factor Peroxisome proliferator-activated receptor gamma (PPARγ) are two key downstream signal factors of the Wnt/β-catenin signalling pathway, which are necessary in bone formation and reconstruction [12, 13] . RUNX-2 is responsible for promoting the differentiation of bone mesenchymal stem cells (BMSCs) into osteoblasts, and PPARγ is responsible for promoting the differentiation of BMSCs into adipocytes [14] . Osteogenic capacity is indicated by the activity of alkaline phosphatase (ALP) and tartaric acid acid phosphatase 5b (TRAP5b) is a typical bone resorption index [15, 16] .
Recent studies showed that GM plays an important role in the host immune system; it promotes normal bone health and inhibits bone loss, which might be the basis of targeted OP therapy [17] [18] [19] . Many studies have focused on regulating GM to improve bone metabolism through probiotics and prebiotics [20, 21] . McCabe et al. investigated that probiotic use could decrease intestinal inflammation and increase bone density in healthy male but not female mice [22] . By feeding Bacillus subtilis, the thickness of the tibia of hens were increased, and the reduction of bone mass caused by Salmonella infection was also effectively prevented [23] . The bone mass of ovariectomized mice lacking estrogen that were fed with Lactobacillus reuteri was significantly higher than that of chow-fed mice, presumably because of the inhibitory effect of Lactobacillus on osteoclasts and the reduction of the inflammation factor expression [20] . Other studies have shown that in addition to promoting the absorption of physical elements, prebiotics could increase bone mineral mineralization and enhance bone mineral density by increasing the content of intestinal probiotics [21] .
The regulation of traditional Chinese medicine (TCM) on GM has attracted increasing attention in recent years. Both theoretical investigations and clinical and animal studies have confirmed that a number of single Chinese herbs or compounds could maintain the balance of intestinal microecology and regulate GM. Studies have shown that TCM could improve the animal model of OP by increasing the bone density and serum estradiol levels, promoting bone formation, inhibiting bone resorption, and regulating bone reconstruction balance [24] [25] [26] . Moreover, clinical data revealed that TCM could increase the lumbar spine and other parts of the bone density of the patients with OP and significantly relieve the pain caused by OP [27, 28] . Eclipta prostrata, a species of plant in the sunflower family, has been used for treating uterine bleeding, loose teeth, tinnitus and dizziness in traditional medical record [29] . Our previous clinical trial found that the formula containing E. prostrata effectively treated perimenopausal symptoms [30] . E. prostrata contains various active ingredients, including triterpenes, flavonoids, thiophenes [31] [32] [33] [34] . The main compounds of E. prostrata extract were identified as ecliptasaponin IV, ecliptasaponin A, apigenin, luteolin, luteolin-7-O-glucoside [35] . Pharmacological studies have shown that E. prostrata display hepatoprotective, haemostatic, anti-tumour, anti-inflammatory, anti-hypertensive, hypoglycemic and anti-OP effects [36] [37] [38] [39] [40] [41] [42] [43] . Even though many different monomer components have been reported to possess anti-OP effects, the combined effect of E. prostrata should be further explored.
Experimental studies on the pharmacokinetics of TCMs have demonstrated that their absorption and bioavailability was related to the intestinal system [44] . In addition, in view of the low plasma concentration, TCMs are suspected to have an indirect effect caused by the interaction of intestinal microflora and the metabolism of effective ingredients from TCMs (data not shown and manuscript in preparation). Recent studies demonstrated that the effect of the GM on the bone mass was mediated by the effects on the immune system, which in turn regulated osteoclast genesis [45, 46] . Sjogren showed that GM loss decreased the number of CD4 + T cells in the spleen involved in bone absorption [19] . Although the interaction among GM, the immune system and bone health has been established [45] , the anti-OP mechanism of E. prostrata via GM remains unclear.
In this study, we reported the effects of E. prostrata on GM for preventing OP in mice. The results of the high-throughput sequencing of GM and bone factor analysis identified the potential microbial targets of E. prostrata and the related GM to bone health in OP treated by E. prostrata. We also suggested that E. prostrata might be a promising therapeutic TCM for OP prevention and treatment.
METHodS

Experimental animals
Experimental animals including 4-month-old male senescence-accelerated mice P6 (SAMP6; SPF level) with OP and 4-month-old male anti-senescence-accelerated mice R1 (SAMR1; SPF level) were provided by Department of Experimental Animal Science of Peking University Health Science Center (Beijing, China). Animals were raised in Institute of Radiation Medicine Chinese Academy of Medical Sciences (Tianjin, China), at room temperature (22±2 °C), with relative humidity of 58-65 % and light cycle of 12 h alternation. In this study, ten same-treated mice were tested for each group (five per cage).
Experimental strain and medium
The micro-organism Lactobacillus bulgaricus CICC6045 used in this study was purchased from Guangdong Culture collection center and preserved at Tianjin University of Traditional Chinese Medicine. Lactococcus lactis NZ9000 was given as a present from University of Groningen and HeFei University of Technology. All medium components used in this study were reagent pure grade purchased from Jinsong Biotechnology (Tianjin, China). All other chemicals used were of analytical grade unless otherwise stated. The strain L. bulgaricus CICC6045 and L. lactis NZ9000 was activated by transferring single colonies of the strain from plates to 10 ml activation MRS medium extract in 50 ml static flask at 37 °C, for 24 h. The cells of these two strains were collected by centrifuged at 4000 r min −1 for 15 min and resuspended in normal saline and then prepared to be microbial agent of 10 8 c.f.u. ml −1 for further animal feeding. The bacteria solution was administrated by gavage to P6 mice with OP.
Preparation and dose of E. prostrata
E. prostrata L. was purchased from Anguo Qi-an Pharmaceutical. Altogether, 2 kg of dried E. prostrata was refluxed by 70% EtOH twice (2 h per time), then the extract was concentrated under vacuum to 200 g and stored at 4 °C for feeding. The E. prostrata extract (by EtOH) was further qualitatively and quantitatively analysed by UHPLC-Q-TOF-MS and UPLC-MS/MS, respectively [35] . The low group raw dose of E. prostrata (EHB) for treating P6 mice was designed as 2.4 g kg −1 and the high group (EHA) was 4.8 g kg −1 , correspondingly the extract dose was 0.24 g kg −1 and 0.48 g kg −1 ( Table 1) . The above extracts were dissolved into water for regularly feeding per mice per day for 12 weeks. The control group of R1 mice and the model group P6 mice were given the same volume of pure water. The TCM was intragastrically administered to mice and mice feed meet the SPF level nutrition needs.
Bone micro-architecture assessment by microcomputed tomography (micro-CT)
The double long bone and muscle tissue of mice were separated in d-PBS by sterile scissor forceps and then placed in the whole culture of αMEM with 10% FBS and 1% double antibody. Afterwards the bone marrow was removed for protein extraction. Before micro-CT scanning, the femur was placed vertically in the sample container along the long axis, and the right gauze was filled around to fix the sample. The Viva CT40 system was performed for x-ray examination and x-ray images were obtained. The appropriate location and length were selected on the x-ray image and then the CT scanning program started scan samples. Micro-CT conditions for scanning the femur of SAMP-6 mice were set at a voltage 70 kVp with current of 111 μA. After automatic reconstruction, 2D slices and 3D was produced by 50 episodes of 1.05 mm of femur epiphyseal line. After choosing the range of interest (ROI), bone parameters were calculated by the software. The bone micro-structural parameters for the determination included bone volume fraction (BV/TV), bone mineral density (BMD), trabecular number (Tb. N.), trabecular thickness (Tb. Th.), trabecular separator (Tb. Sp.), structure model index (SMI) and degree of anisotropy (DA).
detection the bone-relating factor RunX-2, oPG, RAnKL, PPARγ, TRAP5b and ALP The bone marrow was collected from bone of SAMP6 mice and resuspended in 1 ml PBS. Then, 4 ml RBC lysate was added for 10 min lysis on ice after centrifugation and discarding the supernatant. Next, 150 µl RIPA was added for 30 min lysis on ice after centrifugation and discarding the supernatant. Then the bone marrow protein was separated in the supernatant by centrifugation and quantified by bicinchonininc acid (BCA). Western blotting was performed to determine the expression of RUNX-2, OPG, RANKL and PPARγ relating to osteoblasts and osteoclasts [47] . The electrophoresis strips were photographed and quantified by Gene Genins Bio Imaging System. Moreover, TRAP5b was detected by its Elisa Kit (ISD; UK) for quantitative bone resorption detection and ALP was detected by its Kit (Biyuntian, Tianjin) for osteogenic capacity in plasma samples of mices.
All statistical analysis was completed by Microsoft Office EXCEL2007 and SPSS software. Measurement data were expressed by mean±standard deviation, and one-way ANOVA was used for statistical analysis. The homogeneity of variance was tested. If the data variance was homogeneous, LSD test would be used; if the data variance was not uniform, Dunnett-t3 test would be used. The difference was statistically significant with *P<0.05 or **P<0.01.
Faecal sample collection and genome dnA extraction
Fresh stool samples of each group (three of ten mice per group) were collected in sterile tubes, then frozen and stored at −80 °C before being culled. Afterwards, total genome DNA from samples was extracted using the CTAB/SDS method according to the molecular cloning booklet. Sample DNA concentration and purity were monitored by 1% agarose gels. According to the concentration, DNA was diluted to 1 ng μl −1 using sterile water [48] . Genome DNA were then sent for sequencing (Novogene, Beijing, China). 
16S rRnA PCR and Illumina sequencing
The bacterial 16S ribosomal RNA gene V4 region was amplified by PCR. The following PCR primers were used: 515F 5′-GTGCCAAGCMGCCGCGGTAA-3′ and 806R 5′-GGACTACHVGGGTWTCTAAT-3′. All PCR reactions were carried out with Phusion High-Fidelity PCR Master Mix (New England Biolabs). Amplification factor: 95 °C, 3 min; 95 °C, 30 s, 55 °C, 30 s, 72 °C 60 s, 30 cycle; 72 °C, 5 min; 4 °C termination reaction. PCR products were then mixed with the same volume of 1X loading buffer (contained SYB green) and detected on 2% agarose gel by electrophoresis. Samples with bright main strip between 400-450 bp were chosen for further experiments. PCR products were mixed in equidensity ratios. Then, mixture PCR products were purified with Qiagen Gel Extraction Kit (Qiagen, Germany). Sequencing libraries were generated using TruSeq DNA PCR-Free Sample Preparation Kit (Illumina, San Diego, USA) following the manufacturer's recommendations and index codes were added. The library quality was assessed on the Qubit 2.0 Fluorometer (Thermo Scientific) and Agilent Bioanalyzer 2100 system. At last, the library was sequenced on an Illumina HiSeq 2500 platform and 250 bp paired-end reads were generated.
data analysis
Raw paired-end reads was quality-filtered based on their unique criteria by truncating the low score, mismatching or ambiguous region. High-quality paired-end reads were merged and assembled to raw tags based on overlap sequence using FLASH (V1.2.7, USA) [49] . Raw tags were then performed to QIIME quality controlled process (V1.7.0, USA) under specific filtering conditions to obtain the high-quality clean tags [50] . Compared with the reference database (Gold database), chimera sequences were removed by UCHIME algorithm (USA) [51] . Then the effective tags were finally obtained. Operational taxonomic units (OTUs) were clustered with ≥97% sequence similarity by Uparse software (Uparse v7.0.1001, USA) [52] . Representative sequence for each OTU was screened and performed to Ribosomal Database Project (RDP) classifier (V2.2, USA) [53] , algorithm using the Green Gene Database [54] for taxonomic annotation. In order to study the phylogenetic relationship of different taxonomic levels (Phylum, Class, Order, Family, Genus) classified from OTUs, and the difference of the dominant species in different groups, multiple sequence alignment was conducted using the muscle software (V3.8.31, USA) [55] . Abundance information of OTUs was normalized using a standard of sequence number corresponding to the sample with the least sequences. Subsequent analysis of alpha diversity and beta diversity were all performed based on this output normalized data.
Alpha diversity is applied in analysing the complexity of species diversity for a sample through six indices, including observedspecies, Chao1, Shannon, Simpson and ACE [56] . All these indices in our samples were calculated with QIIME (V1.7.0) and displayed with R software (V2.15.3). Beta diversity analysis was used to evaluate differences of samples in species complexity, Beta diversity on both weighted and unweighted unifrac were calculated by QIIME software (V1.7.0). Principal coordinate analysis (PCoA) was performed to get principal coordinates and visualize from complex, multidimensional data [57] . A distance matrix of weighted or unweighted unifrac among samples obtained before was transformed to a new set of orthogonal axes, by which the maximum variation factor is demonstrated by first principal coordinate, and the second maximum one by the second principal coordinate. PCoA analysis was displayed by WGCNA package, stat packages and ggplot2 package in R software (V2.15.3). The enriched and significant bacteria in each group were identified by linear discriminant analysis (LDA) combined with effect-size measurements (LEfSe), with P<0.05 [58] .
In vitro assay of effect of E. prostrata on bacteria , 10 8 times with MRS medium. Then 100 µl of each dilution culture was plated on the medium and cultured at 37 °C for 24 h to count colonies. The suitable dilution multiple was used for inoculum culture and testing the following assay.
The MRS medium containing different concentration of E. prostrata extract was used for culturing L. bulgaricus CICC6045 and L. lactis NZ9000. Before addition of E. prostrata extract into MRS medium, the medium was sterilized by autoclaving at 121 °C for 15 min. E. prostrata extract was resolved in 70% EtOH and then was added into the medium after passing through a 0.45 mm membrane filter. The concentrations of E. prostrata extract were finally adjusted to 10 −4 to 10 2 mg ml −1
. The plate with no E. prostrata extract was tested as control. Afterwards, strain culture was plated on the prepared medium and aerobically incubated for 24 h (stationary growth phase reached) at 37 °C. The growth value was equal to the colony numbers of strains incubated with E. prostrata extract for 24 h divided by the colony numbers of strains incubated without E. prostrata extract for 24 h. The colony numbers were obtained by counting the incubation plates. Two plates were prepared for each condition, and each experiment was repeated twice. A growth value >1.0 indicates the promotion activity of E. prostrata extract, whereas a growth value <1.0 indicates its inhibitory activity.
RESuLTS
E. prostrata affects bone micro-architecture of SAMP6 mice
The bone micro-architecture of different treatment mice was detected by micro-CT. Compared to SAMR1 mice, SAMP6 (model) mice had more deteriorated micro-architecture, while the bone condition of mice treated with 0.48 g kg −1 extract of E. prostrata (EHA) for 12 weeks was improved (Fig. 1a) . We also found that SAMP6 (model) mice had lower BMD, BV/TV, Tb. N., Tb. Th., higher Tb. Sp., DA and SMI compared with those of SAMR1 mice. And EHA significantly increase BV/TV, Tb. N., Tb. Th. and decrease Tb. Sp., SMI compared to SAMP6 mice (P<0.05). However, no significant changes were observed at the lower dose (EHB) (Fig. 1b-h ).
Molecular mechanism of anti-oP of E. prostrata in SAMP6 mice
Results showed that compared with the SAMR1 mice, RUNX-2 and RANKL in the bone marrow of the SAMP6 mice was higher, but decreased after treating with 0.48 g kg −1 extract of E. prostrata (EHA) (Fig. 2a, c) . The OPG/RANKL ratio in the bone marrow cells of the high dose (EHA) group was increased and the level of bone absorption index TRAP5b in plasma was decreased (see Fig. 2b, e) , indicating that the formation of osteoclasts in SAMP6 mice was reduced and the bone resorption rate was slowed down. In addition, our study found that EHA could reduce PPARγ, which was the key factor of SAMP6 mice bone marrow cells differentiating into adipocytes (Fig. 2d) . Results also showed that compared with the SAMR1 group, the ALP activity of the SAMP6 group was significantly decreased, while EHA could significantly enhance the ALP activity (P<0.05), which was related to the osteogenesis ability (Fig. 2f) . Our study suggested that 0.48 g kg −1 extract of E. prostrata (EHA) might be able to alleviate the effect of OP by inhibiting osteoclast, increasing the number of osteoblasts and regulating the dynamic balance of bone absorption and bone formation.
Sequence data and diversity analysis of gut microbiota
The composition of GM of each group was determined by performing an Illumina-based analysis of bacterial 16S rRNA (V4 region) in faeces [59] . By removing unqualified sequences, an average of 76 213 effective tags were obtained. After selecting the effective reads, each faecal sample (three for each group) produced an average of 74 982 effective reads for an average of 740 OTU clusters.
Results of OTU analysis suggested that E. prostrata feeding significantly altered OTU compositions compared with chow feeding of fast aging P6 mice. Both high dose and low dose E. prostrata feeding of fast aging P6 mice showed the most OTUs for modulating the GM in our model, while chow feeding anti-fast aging R1 mice showed the . The above extracts were dissolved into water for regularly feeding per mice per day for 12 weeks. The control group of R1 mice and the model group P6 mice were given the same volume of pure water.
least. In the E. prostrata-fed P6 group, supplementation with high dose (EHA) and low dose (EHB), respectively, there are 755 and 764 common OTUs with chow-fed P6 mice, resulting in significant changes in a total of 20% distinct OTUs. Among the shared 683 OTUs of P6 mice, there are 537 OTUs shared in all groups, which respectively occupied 74% in R1, 58% in P6, 57% and 52% in E. prostrata-fed P6 groups.
Alpha diversity analysis including Chao (to determine species richness), ACE, Shannon and Simpson indices (to determine species diversity) as well as the observed species numbers were calculated to describe the composition of the bacteria in different treatment samples (Table 2 ). Higher numbers of the estimators represent greater diversity, which suggests that alpha diversity index was enhanced in P6 mice compared with R1 mice, although there were no significant differences among the different treatment of P6 groups, as shown in Table 1 . Rarefaction analyses showed that curves of diversity estimators approached a parallel orientation to the horizontal axis, indicating that the sequencing depth covered rare new species and most of the diversity (Fig. 3a) . UniFrac-based PCoA of beta diversity revealed a distinct clustering of microbiota composition for each treatment group (Fig.  3b) . Multivariate analysis of variance of PCoA matrix scores indicated a statistically significant separation between the microbiota of R1 and P6 groups. Significant separations were also noted for EHA and EHB groups. On the other hand, the GM of EHB mice did not significantly differ from that of chow-fed P6 mice.
The combined data showed high bacterial richness and diversity after E. prostrata treatment. With high dose feeding, the richness and diversity of bacteria in the gut increased more sharply than the low dose group, which were relatively approached to that of chow feeding P6.
Bacterial community comparison of gut microbiota altered by E. prostrata
Detailed analysis of bacterial community was described by phylum, family, genus and species level of different treatment GM. In terms of species annotations, a total of 36 phylums were detected and revealed by the abundance of species. The most abundant phylums accounting for 98.7% of the effective sequence were illustrated in Fig. 4a (Fig. 4a) .
In this study, a total of 148 families, 284 genera were found. The species abundance was displayed by the density of colour in heatmaps, and clustered according to the similarity of the abundance of each species, which can reflect the similarity and difference of the bacterial composition among the samples. The vertical clustering of the heatmap reflects the similarity of all species in a sample. The lateral clustering reflects the similarity of the abundance of a species in each sample. The shorter the length, the closer the distance is, and the closer the GM composition is. The heatmap showed the top 35 genus levels (Fig. 4b, c) . WCHB1-02, unidentified_Hydrogenedentes, Ignavibacteriaceae and BSV26 and some other low ratio families (Fig. 4b ).
In the GM of P6 mice, bacterial genera including (Fig.  5b) . Collectively, these results showed that EHA modulates the GM of P6 mice, resulting in a microbiota composition similar to that of healthy mice.
We further applied linear discriminant analysis (LDA) combined effect size measurements (LEfSe) to explore the significant changes and relative richness of the bacterial community in the chow-fed P6 mice, E. prostrata-fed P6 mice, and chow-fed healthy R1 groups, at genus levels. Fig.  6 summarizes the enrichment and variations in bacterial community for all four groups. At the genus level, Lactobacillus was enriched in the R1 group; Parabacteroides and Blautia were enriched in the P6 group; Lactococcus was enriched in the EHA group; and Lachnoclostridium and Helicobacter were enriched in the EHB group, respectively, which are consistent with other levels. The significance and variance of bacterial communities, as determined by sequencing analysis, may help discriminate OP mice from healthy subjects, and implied the potential microbe targets of E. prostrata and the GM-biomarkers of bone health in OP treated by E. prostrata.
E. prostrata promotes the growth of Lactobacillus and Lactococcus strain
The effect of E. prostrata extract on the Lactobacillus and Lactococcus growth was investigated using L. bulgaricus CICC6045 and L. lactis NZ9000. The 10 4 -dilution multiple of inoculum culture were used for testing. When Lactobacillus strain was incubated with conjugated 10 −1 mg ml −1 E. prostrata extract for 24 h at 37 °C, a high growth value (2.0) was observed. The growth value was higher with the increasing concentration of conjugated E. prostrata extract from 10 −1 to 10 1 mg ml −1 . When the concentration reached 10 1 mg ml −1 , the growth value reached 4.0 and attached to a stationary phase. The lower concentration of E. prostrata extract also promoted the growth of Lactobacillus, but slightly. From the E. prostrata extract concentration of 10 −2 to 10 0 mg ml −1 , the growth value of Lactococcus increased obviously with the increasing concentration from 2.0 to 3.0. Afterwards, the growth value of Lactococcus did not change according to the higher concentration. In other words, E. prostrata extract were able to promote the Lactobacillus and Lactococcus growth at a broad concentration spectrum (Fig. 7) .
Lactobacillus and Lactococcus strains relieve oP of SAMP6 mice GM diversity was also analysed by phylum and genus level of bacterial treatment GM. Compared with the former P6 mice treated with E. prostrata, GM of these two-group Lb. and Lc., treated by Lactobacillus and Lactococcus respectively, showed similar composition at phylum level and different from the P6 group, with an increased Firmicutes, Proteobacteria and Actinobacteria, decreased Bacteroidetes. At genus level, the abundance of Lactobacillus was respectively increased in both Lb. and Lc. group, while Lactococcus was not obviously changed in each group. In addition, bacterial genera including Bacteroides, Parvibacter and Alistipes were decreased in the Lb. group; and bacterial genera including Ruminococcaceae, Lachnoclostridium, Desulfovibrio, Candidatus_Sacharimonas, Intestinimonas and Odoribacter were increased in the Lb. group; while in the Lc. group, Lachnoclostridium, Enterobacteriaceae, Acinetobacter were increased, Bacterioides was decreased (Fig. 8a) . Among the genera discovered in this study, Lactobacillus was both enriched in the EHA group and bacterial groups compared with the OP group (Fig. 8b) . The OP condition was determined by analysing the bone micro-architecture of bacterial treatment of Lactobacillus and Lactococcus strains. Compared to P6 mice (model), the Lactobacillus-treated group for 12 weeks had more improved micro-architecture than the Lactococcus treated group, and the bone condition of mice treated with 0.48 g kg −1 extract of E. prostrata (EHA) for 12 weeks was similarly improved (Fig. 8c) . In detail, the Tb. N., Tb. Th. of probiotic group were increased, while Tb. Sp. was decreased, which showed an opposite tendency in P6 mice. Lactobacillus significantly increase Tb. N. and Tb. Th.; and decrease Tb. Sp., similar to the results of the E. prostrata-treated group. Collectively, these results showed that E. prostrata modulates the GM of P6 mice by increasing Lactobacillus, resulting in anti-OP function.
dISCuSSIon
E. Prostrata is a natural herb with homology of medicine and food, enriched in various regions of China, and has been used for medicinal purposes for a long time [60] . Previous studies have shown that E. Prostrata extracts from both different parts and of different chemical compositions possess anti-OP activities [43] . According to Deng, 15 mg kg −1 of echinocystic acid from E. Prostrata could prevent bone mass reduction in rats [42] . Our results revealed that 0.48 g kg −1 extracts of E. Prostrata significantly improved the bone structure, which was consistent with traditional medical records. According to sequencing data, as for mice differences, the bacterial diversity of R1 mice was significantly lower than P6 mice. Moreover, EHA had influence on the GM composition. Combined with the analysis of bone micro-structure above, it could be explained by the fact that there was interaction between GM and bone health [19, 45] . The dose could directly affect the GM diversity. In addition, the high dose group has more ability to change the condition of OP by 12 weeks compared with the low dose group. And the bone health might play an important role in the GM condition, and make the difference. The real reason needs to be further verified. These findings suggested that E. Prostrata may serve as a new candidate or a leading compound for modern medical prevention and treatment of OP.
In recent years, many studies have shown that probiotics, prebiotic, diet, TCM and exercise influence the regulation of GM in improving bone metabolism [4, 61] . In particular, a treatment of probiotics L. reuteri significantly increased the bone mass of castrated estrogen-deficient mice, and the osteoblast was inhibited by the immune system [20] . In our study, Lactobacillus genus was detected as the biomarker in GM of anti-fast aging mice and Lactococcus in GM of EHA mice. It also displayed a protective function against pathogens Escherichia-Shigella, Parabacteroides and Blautia. Not only Lactobacillus but also probiotics such as Lactococcus and Bifidobacterium were enriched in the EHA group. E. prostrata is suspected to promote the growth-related conditions of probiotics, thereby improving the health condition and relieving disease. To verify this presumption, the interactions of the Lactobacillus and Lactococcus strain with E. prostrata were preliminarily studied. Our observations suggested that E. prostrata extract could promote both Lactobacillus and Lactococcus growth in vitro not only at low but also at high concentrations; these findings corresponded with pharmacological results of this study. E. prostrata extract feeding might promote the growth of the Lactobacillus and Lactococcus genus strains in the gut at suitable concentrations. Therefore, the isolation and identification of the targeted strains from GM should be further explored. Moreover, by probiotic feeding experiment, P6 mice with OP showed an improved bone condition compared with the group without feeding. The Fig. 6 . LEfSe at different levels of each group. The linear discriminant analysis (LDA) combined with effect-size measurements (LEfSe) are used to find a statistically significant biomarker between groups and groups, that is, species with significant difference among groups. The LDA value distribution histogram shows that the LDA score is greater than the set value (the default setting is 4), that is, the biomarker with statistical difference between the groups. The species with different abundance in different groups are shown. The length of the histogram represents the size of the difference species (i.e. LDA score). 'g represented for genus', 'o_order', 's_specie', 'f_family', 'c_class'.
proportion of Lactobacillus and Lactococcus was enhanced by E. prostrata, which was probably exerting a beneficial effect on bone health by promoting the growth of Lactobacillus. We suggested that the anti-OP mechanism of TCM E. prostrata might be related with GM.
TCMs can reportedly greatly improve the treatment of common diseases. For example, with the intervention of Ganoderma lucidum water extract, the abundance of obesityrelated bacteria Enterococcus spp. of high-fat diet mice was reduced; Bacteroides spp. was increased; and the ratio of Firmicutes to Bacteroides was decreased [62] . Stappenbeck and Steed [63] identified a microbe that was suspected to prevent the damage caused by flu. This micro-organism named Clostridium orbiscindens was demonstrated to degrade flavonoids and produce metabolites that enhance the interferon signal. Recent studies have posited that GM plays a role in various brain disorder diseases, such as autism, Parkinson's disease and multiple sclerosis. However, further work is needed to study the specific relationships between GM and more common diseases [64] . Microbial treatment (including prebiotics, probiotic and TCM) should be developed to improve the treatment of intestinal symptoms and other kinds of diseases [65] .
Although microbial genomes are considerably smaller than the host, the microbiota has a potentially greater metabolic capability, and could affect the bio-availability of certain oral drugs [66] . Analysis of the microbiota relationship suggested that TCM might prevent different diseases simultaneously [36] [37] [38] [39] [40] [41] [42] [43] . However, the specific bacterium or community involved in the TCM metabolic system remains unknown. Moreover, mining the metabolic activity of the GM might yield novel therapeutic agents degraded by TCM. Studying the mechanism of TCM would point out a new direction and process toward promoting the modernization and internationalization of TCM. TCM is closely related to the immune system. Liu et al. [67] indicated that E. prostrata could increase the proportion of CD4 + T lymphocytes in immunosuppressed mice and stimulate the immune function. According to this study, E. prostrata also had influence on the GM and OP. Based on the previous study showing the relationship among bone, immune system and GM [19, 45] , further study on the function and mechanism of E. prostrata on GM via immune system is full of research value.
Since the intestinal flora of mice differed from that of humans, and the mice used in this study were not humanized, further clinical tests on humans are needed. Wang et al. [57] demonstrated that the Blautia, Parabacteroides and Ruminococcaceae genera differed significantly between the OP and NC patients. This finding was slightly inconsistent with our results. Increasing animal studies have suggested that a number of TCMs likely induced a pharmacological effect through GM. As such, the use of large-scale clinical specimens is proposed for conducting TCM-microbiological research or intestinal flora of humanized animals.
ConCLuSIon
In conclusion, the TCM E. prostrata possesses an important activity for the prevention and treatment of OP by regulating GM in mice. Further studies on TCM-microbiota therapies must be conducted to expand the scope in clinical practice.
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